Analyses of expression patterns from cancer samples versus normal samples indicated that SALL2 has differential expression in 16 out of 21 cancer types, most significantly in the brain, colorectal, and testis tissues (Supplementary Table 2, p-values). This evidence concerns the gene SALL2 and cancer.